These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8822129)

  • 1. Indications and drugs for anticoagulation therapy in children.
    Andrew M
    Thromb Res; 1996; 81(2 Suppl):S61-73. PubMed ID: 8822129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M; Desruennes E; Di Palma M
    Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparins in the long-term treatment of venous thromboembolism.
    Liapis CD; Daskalopoulos ME; Daskalopoulou SE
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Monagle P; Chan A; Massicotte P; Chalmers E; Michelson AD
    Chest; 2004 Sep; 126(3 Suppl):645S-687S. PubMed ID: 15383489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.
    Michaels LA; Gurian M; Hegyi T; Drachtman RA
    Pediatrics; 2004 Sep; 114(3):703-7. PubMed ID: 15342842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children.
    Nowak-Göttl U; Bidlingmaier C; Krümpel A; Göttl L; Kenet G
    Br J Pharmacol; 2008 Mar; 153(6):1120-7. PubMed ID: 17906688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin for the treatment of venous thromboembolism.
    Hirsh J
    Am Heart J; 1998 Jun; 135(6 Pt 3 Su):S336-42. PubMed ID: 9628447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin in children.
    Albisetti M; Andrew M
    Eur J Pediatr; 2002 Feb; 161(2):71-7. PubMed ID: 11954754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
    Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
    J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
    Mavrakanas T; Bounameaux H
    Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and coagulation.
    Khorana AA
    Am J Hematol; 2012 May; 87 Suppl 1(Suppl 1):S82-7. PubMed ID: 22389165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin in pregnancy: current issues.
    Greer I; Hunt BJ
    Br J Haematol; 2005 Mar; 128(5):593-601. PubMed ID: 15725079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation therapy in children.
    Ronghe MD; Halsey C; Goulden NJ
    Paediatr Drugs; 2003; 5(12):803-20. PubMed ID: 14658922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview on guidelines and recommendations for generic low-molecular-weight heparins.
    Harenberg J
    Thromb Res; 2011 Feb; 127 Suppl 3():S100-4. PubMed ID: 21262425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.